First Greek rapid antigen test enters final stretch

First Greek rapid antigen test enters final stretch

Τhe production of the first Greek rapid antigen test for the study and defeat of the Covid-19 pandemic has entered the final stretch.

The results of the research, which involved the synthesis, isolation and characterization of a series of monoclonal antibodies against the coronavirus SARS-CoV-2, were submitted in the framework of a patent application to the Industrial Property Organization (OBI).

The project was undertaken with the backing of a program by the Development and Investment Ministry which allocated approximately 2.9 million euros.

The next step is the search for a company that will undertake the mass production of monoclonal antibodies and place them on special membrane to create a rapid antigen test. 

The project involved six research centers and four universities under the supervision and funding of the General Secretariat for Research and Technology. 

Subscribe to our Newsletters

Enter your information below to receive our weekly newsletters with the latest insights, opinion pieces and current events straight to your inbox.

By signing up you are agreeing to our Terms of Service and Privacy Policy.